The use of herbal medicines by people with cancer in the UK: A systematic review of the literature

QJM: An International Journal of Medicine

Volumn 102, Issue 12, 2009, Pages 831-842

  Gratus, C ^a   Damery, S ^a   Wilson, S ^a   Warmington, S ^a   Routledge, P ^b   Grieve, R ^c   Steven, N ^a   Jones, J ^a   Greenfield, S ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PRIMROSE OIL; TAMOXIFEN; PLANT MEDICINAL PRODUCT;

ALTERNATIVE MEDICINE; ARTICLE; ATTITUDE TO HEALTH; BREAST CANCER; CANCER REGISTRY; CANCER STAGING; ECHINACEA; GARLIC; GINKGO BILOBA; GINSENG; HERBAL MEDICINE; HUMAN; HYPERICUM PERFORATUM; NEOPLASM; PATIENT ATTITUDE; PATIENT SAFETY; PELVIS CANCER; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY CONTROL; SABAL; SAMPLE SIZE; SILYBUM MARIANUM; SYSTEMATIC REVIEW; THERAPY EFFECT; TREATMENT RESPONSE; UNCARIA TOMENTOSA; UNITED KINGDOM; MOTIVATION; PHYTOTHERAPY; REVIEW; UTILIZATION REVIEW;

GREAT BRITAIN; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MOTIVATION; NEOPLASMS; PHYTOTHERAPY; PLANT PREPARATIONS;

EID: 77950571094     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcp137     Document Type: Article

References (38)

1. House of Lords Science and Technology Committee 2000 Sixth Report. London.
2. Thomas KJ, Nicholl JP, Coleman P. Use and expenditure on complementary medicine in England: a population-based survey. Complement Therap Med 2001; 9:2-11.
3. Medicines and Healthcare products Regulatory Agency. Public Perceptions of Herbal Medicines. General Public Qualitative and Quantitative Research 2008. London, Ipsos MORI.
4. Frye R, Fitzgerald S, Lagutta T, Hruska M, Egorin M. Effects of St John's Wort on imatinib mesylate pharmokinetics. Clin Pharmacol Ther 2004; 76:323-29.
5. Medicines and healthcare Products Regulatory Agency. Black Cohosh: UK Public Assessment Report 2007. London.
6. Amato P, Christophe S, Mellon P. Estrogenic activity of herbs commonly used as remedies for menopausal symptoms. Menopause 2002; 9:145-50.
7. Corner J. A study of the use of complementary and alternative therapies among people undergoing cancer treatment: A qualitative and quantitative study. Dept of Health NHS R&D Programme 2006. London, Department of Health.
8. Vickers KA, Jolly KB, Greenfield SM. Herbal medicine: women's views, knowledge and interactions with doctors: a qualitative study. BMC Complement Altern Med 2006; 6:40.
9. Cancer Backup [http://www.cancerbackup.org.uk/QAs/83586237] Accessed 15 February 2009.
10. Franklin BD, Seedat H, Heinrich M. Use of herbal remedies by patients admitted to hospital. Pharm World Sci 2007; 29:240-77.
11. Skinner C, Rangasami J. Pre-operative use of herbal medicines: a patient survey. Br J Anaesth 2002; 89:792-5.
12. Evans M, Shaw A, Thompson E, Falk S, Turton P, Thompson T, et al. Decisions to use complementary and alternative medicine (CAM) by male cancer patients: information-seeking roles and types of evidence used. BMC Complement Altern Med 2007; 7:25.
13. Ernst E, Cassileth BR. The prevalence of complementary/alternative medicine in cancer. Cancer 1998; 83:777-82.
14. Spadacio C, de Barros NF. Use of complementary and alternative medicine by cancer patients: systematic review. Rev Saude Publica 2008; 42:1-5.
15. Verfhoef M, Balneaves L, Boon H, Vroegindewey A. Reasons for and characteristics associated with complementary and alternative medicine use among adult cancer patients: a systematic review. Integr Cancer Ther 2005; 4:274-88.
16. World Health Organisation. National Policy on Traditional Medicine and Regulation of Herbal Medicines-Report of a WHO Global Survey 2005. Geneva.
17. Patwardhan B, Warude D, Pushpangadan P, Bhatt N. Ayurveda and traditional Chinese medicine: a comparative overview. Evid Based Complement Alternat Med 2005; 2:456-73.
18. The European Parliament and Council. Directive 2004/24/EC Amending, As Regards Traditional Herbal Medicinal Products, Directive 2001/83/EC on the Community Code Relating to Medicinal Products for Human Use 2004; 136/86.
19. Critical Appraisal Skills Programme (CASP) Qualitative Research Appraisal Tool. [http://www.prhu.nhs.uk/DocLinks/Qualitative%20Appraisal%20Tool.pdf] (last accessed 1 March 2009).
20. McCann LJ, Newell SJ. Survey of paediatric complementary and alternative medicine use in health and chronic illness. Arch Dis Child 2006; 91:173-4.
21. Gami B, Harrington K, Blake P, Dearnaley D, Tait D, Davies J, et al. How patients manage gastrointestinal symptoms after radiotherapy. Aliment Pharmacol Ther 2003; 18:987-94.
22. Rees RW, Feigel I, Vickers A, Zollman C, McGurk R, Smith C. Prevalence of complementary therapy use by women with breast cancer: a population-based survey. Eur J Cancer 2000; 36:1359-64.
23. Wilkinson S, Farrelly S, Low J, Chakraborty A, Williams R, Wilkinson S. The use of complementary therapy by men with prostate cancer in the UK. Eur J Cancer Care (Engl) 2008; 17:492-9.
24. Downer SM, Cody MM, McCluskey P, Wilson PD, Arnott SJ, Lister TA, et al. Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment. BMJ 1994; 309:86-9.
25. Werneke U, Earl J, Seydel C, Horn O, Crichton P, Fannon D. Potential health risks of complementary alternative medicines in cancer patients. Br J Cancer 2004; 90:408-13.
26. Catt S, Fallowfield L, Langridge C. What non-prescription treatments do UK women with breast cancer use? Eur J Cancer Care (Engl) 2006; 15:279-85.
27. Hunter M, Grunfeld E, Mittal S, Sikka P, Ramirez AJ, Fentimen I, et al. Menopausal symptoms in women with breast cancer: prevalence and treatment preferences. Psycho-Oncology 2004; 13:769-78.
28. Molassiotis A, Cubbin D. 'Thinking outside the box': complementary and alternative therapies use in paediatric oncology patients. Eur J Oncol Nurs 2004; 8:50-60.
29. Scott JA, Kearney N, Hummerston S, Molassiotis A. Use of complementary and alternative medicine in patients with cancer: a UK survey. Eur J Oncol Nursing 2005; 9:131-7.
30. Fennell D, Liberato ASQ, Zsembil B. Definitions of CAM use by the lay public. Complement Ther Med 2009; 17:71-7.
31. Han JM, Elkin EP, Silva SJ, Broering JM, Latini DM, Carroll PR. Total and specific complementary and alternative medicine use in a large cohort of men with prostate cancer. Urology 2005; 66:1223-8.
32. Steginga SK, Occhipinti S, Gradner RA, Yaxley J, Heathcote P. A prospective study of the use of alternative therapies by men with localised prostate cancer. Patient Educ Couns 2004; 55:70-7.
33. Harrison RA, Holt D, Pattison DJ, Elton PJ. Who and how many people are taking herbal supplements? A survey of 21,923 adults. Int J Vitam Nutr Res 2004; 74:183-6.
34. Skinner CM, Rangasami J. Preoperative use of herbal medicines: a patient survey. Br J Anaesth 2002; 89:792-5.
35. Pieroni A, Sheikh Q-Z, Ali W, Torry B. Traditional medicines used by Pakistani migrants from Mirpu living in Bradford, Northern England. Complement Ther Med 2008; 16:81-86.
36. Cui Y, Shu X-O, Goa Y, Wen W, Ruan Z-X, Jin F, et al. Use of complementary and alternative medicine by chinese women with breast cancer. Breast Cancer Res Treat 2004; 85:263-70.
37. Cancer Research UK. [http://info.cancerresearchuk.org/cancerstats/incidence/?a=5441#incidenc e] (last accessed 1 April 2009).
38. Newsom-Davis T, Kenny L, Al-Shakarchi I, Wong GE, Waxman J. Voodoo dolls and the cancer patient: patients do trust their doctors. Q J Med 2009; 102:311 9.